Johns Hopkins Medicine

Alzheimer's Disease Research Center

Treatment of Apathy in Dementia

Principal Investigator: Paul Rosenberg, M.D.

The goal of this study is to determine if treating dementia patients with methylphenidate (also known as Ritalin) will reduce symptoms of apathy (lack of interest in activities). Participants in the study will be given either the active drug or a placebo (sugar pill) for 6 months, and will be evaluated monthly.

For more information contact Jasmine Dixon at 410-550-9022.